Novel benzimidazole angiotensin receptor blockers with anti-SARS-CoV-2 activity equipotent to that of nirmatrelvir: computational and enzymatic studies.
Ridgway H, Moore GJ, Gadanec LK, Zulli A, Apostolopoulos V, Hoffmann W, Węgrzyn K, Vassilaki N, Mpekoulis G, Zouridakis M, Giastas P, Vidali VP, Kelaidonis K, Matsoukas MT, Dimitriou M, Mavromoustakos T, Tsiodras S, Gorgoulis VG, Karakasiliotis I, Chasapis CT, Matsoukas JM.
Ridgway H, et al. Among authors: chasapis ct.
Expert Opin Ther Targets. 2024 May;28(5):437-459. doi: 10.1080/14728222.2024.2362675. Epub 2024 Jun 7.
Expert Opin Ther Targets. 2024.
PMID: 38828744